Clinical trial
Staccato Alprazolam Single Dose PK
NCT00444522 · Alexza Pharmaceuticals, Inc., Other · Completed
Key facts
| NCT number | NCT00444522 |
|---|---|
| Title | Staccato Alprazolam Single Dose PK |
| Official title | Safety, Tolerability, and Pharmacokinetics of a Single Dose of StaccatoTM Alprazolam for Inhalation in Normal, Healthy Volunteers |
| Lead sponsor | Alexza Pharmaceuticals, Inc., Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Alprazolam thermal aerosol |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Mar 8, 2007 |
| Last update posted | Mar 14, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: